Atypical Prurigo Pigmentosa Following Ketogenic Diet: Successful Treatment with Doxycycline and Tofacitinib
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0465Keywords:
Prurigo pigmentosa, Ketogenic diet, TofacitinibDownloads
References
Demircioğlu D, Durmaz EÖ, Demirkesen C, Şahin S. Prurigo pigmentosa: review of the literature, impact of ketogenic diets and proposal of a hypothesis. Indian J Dermatol 2025; 70: 146–151. DOI: https://doi.org/10.4103/ijd.ijd_464_22
Xiao A, Kopelman H, Shitabata P, Nami N. Ketogenic dietinduced prurigo pigmentosa (the “keto rash”): a case report and literature review. J Clin Aesthetic Dermatol 2021; 14: S29–S32.
Capucilli P, Wan J, Corry J, Chuang JH, Linn RL, Perman MJ. Prurigo pigmentosa: an itchy, urticarial eruption confused for food allergy. J Allergy Clin Immunol Pract 2018; 6: 1381–1382. DOI: https://doi.org/10.1016/j.jaip.2018.02.033
Liu Y, Li J, Zhou G, Wang J, Chen X, Chen S, et al. Prurigo pigmentosa: a retrospective study of 11 patients. Indian J Dermatol Venereol Leprol 2024; 90: 661–665. DOI: https://doi.org/10.25259/IJDVL_751_2023
Schwartz DM, Kanno Y, Villarino A, Ward M, Gadina M, O’Shea JJ. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov 2017; 16: 843– 862. DOI: https://doi.org/10.1038/nrd.2017.201
Navarro-Triviño FJ, Pérez-López I, Ruiz-Villaverde R. Doxycycline, an antibiotic or an anti-inflammatory agent? The most common uses in dermatology. Actas Dermosifiliogr 2020; 111: 561–566. DOI: https://doi.org/10.1016/j.adengl.2019.12.014
Rajput Khokhar A, Ghoreschi K, Huynh J. Adverse effects of Janus kinase inhibitors with relevance for daily practice in dermatology. J Dtsch Dermatol Ges 2025; 23: 1127–1140. DOI: https://doi.org/10.1111/ddg.15796
Waitayangkoon P, Moon SJ, Tirupur Ponnusamy JJ, Zeng L, Driban J, McAlindon T. Long-term safety profiles of macrolides and tetracyclines: a systematic review and meta-analysis. J Clin Pharmacol 2024; 64: 164–177. DOI: https://doi.org/10.1002/jcph.2358
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
